Alpha Teknova, Inc.(TKNO)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Alpha Teknova, Inc. (TKNO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TKNO at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,613 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (7.8) and balance sheet strength (12.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 18.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Alpha Teknova, Inc. reports quarterly revenue of $12.2M, net income of $-3.2M, free cash flow of $-596.0K. Top institutional holders of TKNO by reported 13-F value include ROYCE & ASSOCIATES, VANGUARD CAPITAL MANAGEMENT, Roubaix Capital, based on the most recent SEC filings. TKNO trades on the Nasdaq exchange and files with the SEC under CIK 1850902. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TKNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alpha Teknova, Inc. directly from SEC EDGAR.

AI Quality Score

26.6/100

AI Rank

#2,613

Revenue

$12.2M

Net Income

$-3.2M

Free Cash Flow

$-596.0K

TKNO key financials by period

Alpha Teknova, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$40.5M$-17.3M-41.9%
FY 202410-K$37.7M$-26.7M-69.3%
FY 202310-K$36.7M$-36.8M-96.9%
FY 202210-K$41.4M$-47.5M-119.9%
FY 202110-K$36.9M$-9.8M-32.6%
FY 202010-K$31.3M$3.6M14.9%

Institutions holding TKNO

Institutional investors reporting a position in Alpha Teknova, Inc. on SEC Form 13F.
InstitutionSharesValueReported
ROYCE & ASSOCIATES1,661,395$9.4M2026-06-30
VANGUARD CAPITAL MANAGEMENT1,614,045$9.2M2026-06-30
Roubaix Capital1,579,404$9.0M2026-06-30
BlackRock879,786$5.0M2026-06-30
UBS Group AG631,967$3.6M2026-06-30
Conestoga Capital Advisors314,554$1.8M2026-06-30
GEODE CAPITAL MANAGEMENT311,818$1.8M2026-06-30
BANK OF AMERICA255,760$1.5M2026-06-30
GOLDMAN SACHS GROUP172,017$977.1K2026-06-30
STATE STREET164,885$936.5K2026-06-30
TKNO

Alpha Teknova, Inc.

TKNO
NasdaqSmall CapHealthcare

13F Pro Quality Score

26.6/100

Rank #2,613 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

48.2/100

Profitability

13.1/100

Balance Sheet

12.7/100

Earnings Quality

37.6/100

Free Cash Flow

13.8/100

Institutional Flow

54.5/100

Revenue Scale

7.8/100

Dilution Risk

18.1/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$12.19M

Net Income

Q2 2026
EDGAR

$-3.17M

EPS (Diluted)

Q2 2026
EDGAR

$-0.06

ROIC

Q2 2026
EDGAR

-15.3%

Free Cash Flow

Q2 2026
EDGAR

$-596.0K

Debt/Equity

Q2 2026
EDGAR

0.21

Top Institutional Holders

as of Q2 2026
$51.73M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…